Glioma Records a Chinese Specialist Needs: What to Prepare

Glioma Records a Chinese Specialist Needs: What to Prepare
Key Takeaways
- The glioma records a Chinese specialist needs are a complete diagnostic set: contrast-enhanced MRI with DICOM files, the original pathology report and slides or blocks, molecular marker results, and a clear treatment history.
- Remote review through a written second opinion or video consultation lets a Chinese neurosurgery team assess your case before you commit to travel.
- Most international patients cannot book a standard public hospital outpatient slot from abroad in advance, and the glioma records a Chinese specialist needs must be translated and organized first.
- No service can promise admission, a specific surgeon or a clinical outcome; what records can do is clarify whether a feasible plan exists.
The Problem: Why Glioma Records Get Lost in Transit
Glioma is a rare tumor, and it is treated in a small number of specialist centers. In the United States, the Central Brain Tumor Registry of the United States reports that gliomas make up roughly a quarter of all primary brain and central nervous system tumors, and that the incidence of the most aggressive form, glioblastoma, rises sharply with age. For a patient or family facing this diagnosis, the practical difficulty is not finding information — it is assembling a file that a specialist in another country can actually read.
Records arrive in fragments. An MRI is handed over as a few printed images rather than the full DICOM series. The pathology report names a grade but omits the molecular markers that now determine treatment. Prior surgery notes, radiation plans and chemotherapy cycles sit in different portals. A neurosurgeon reviewing a glioma case needs all of it, in one place, in a language they read fluently.
Families often discover this at the worst moment: after paying for flights, or after a hospital abroad asks for documents they do not have. This is exactly where our team spends most of its time — not diagnosing, but making a glioma file legible to the people who will.
Why China’s Neuro-Oncology Centers Are Worth a Serious Look
China treats a very high volume of glioma cases, and volume matters in neuro-oncology. Surgery for tumors near eloquent cortex, awake craniotomy, molecular stratification and radiotherapy planning are skills refined by repetition.
Specialist depth concentrated in a few cities
China has more than 35,000 hospitals, but the top 5% — the group ranked by Fudan University and JCI accreditation — sit in a small number of cities. Beijing has the largest cluster of Fudan Top 100 hospitals (21), followed by Shanghai (18) and Guangzhou (10). Neurosurgery is one of the 45 specialties ranked individually on the Fudan specialty reputation list, which names a top 10 for each field. You can review which hospitals appear in that neurosurgery group on our specialty rankings by department page.
Diagnostic infrastructure at scale
Major Chinese hospitals run high-field MRI and PET imaging with rapid turnaround, and molecular pathology — IDH mutation, 1p/19q codeletion and MGMT promoter methylation testing — is standard at the leading neuro-oncology centers because WHO classification now requires it. That matters: the 2021 WHO classification of central nervous system tumors made molecular markers part of the diagnosis itself, not an optional extra.
Cost differential, stated honestly
Cost is a real factor for many families, and it should be discussed without exaggeration. Surgical and hospital charges at Chinese public tertiary hospitals are generally lower than at Western academic centers, but glioma treatment is a long pathway — surgery, radiotherapy, chemotherapy, imaging surveillance — and the total depends on the hospital, the ward class and the complexity of the case. We do not publish a single figure for glioma care because any such number would be misleading. What we can do is help you obtain a written estimate from the specific hospital after the records have been reviewed.
What Records a Chinese Specialist Actually Needs
Below is the working checklist our team uses when preparing a glioma file for review by a Chinese neurosurgery or neuro-oncology department. Not every item exists for every patient, and that is normal. The goal is completeness, not perfection.
| Record category | What to send | Why the specialist needs it |
|---|---|---|
| Imaging | Full DICOM files from every MRI, including contrast-enhanced T1, T2/FLAIR and diffusion sequences; CT and PET if performed | Printed films lose detail; the surgeon needs the original series to assess location, eloquence and resectability |
| Pathology | Original pathology report plus, where possible, unstained slides or the paraffin block | Chinese centers usually re-review glioma tissue in-house before planning treatment |
| Molecular markers | IDH1/2, 1p/19q codeletion, MGMT promoter methylation, ATRX, EGFR amplification, TERT where tested | These define the integrated diagnosis and shape the treatment recommendation |
| Surgical history | Operative notes, extent of resection as documented, any complications | Determines whether further surgery is feasible or advisable |
| Adjuvant treatment | Radiation dose and fields, chemotherapy agents, cycles and dates, toxicities | Prior radiotherapy limits options and must be known before any new plan |
| Current status | Recent neurological exam, seizure history, steroid and antiepileptic doses, blood counts and liver function | Establishes fitness for anesthesia and any proposed therapy |
| Identity and logistics | Passport copy, date of birth, contact details, insurance documents if any | Required for hospital registration and any medical card creation |
How the Review Process Works, Step by Step
Understanding the sequence prevents wasted travel. This is how a remote glioma review typically unfolds through our service.
Step 1 — Records collection. You gather the items above. We provide a checklist and can arrange certified medical translation into English or Chinese as the receiving hospital requires.
Step 2 — Written second opinion. The relevant Chinese specialty reviews your existing reports and returns written analysis, treatment suggestions and direction. This is a document for discussion with your own physicians — for reference only, not a prescription.
Step 3 — Video consultation. If you want to hear the reasoning directly, the specialty team meets you online to discuss symptoms, goals and their recommendations, with interpretation.
Step 4 — Proxy consultation, if useful. You may designate a city, hospital, department or specialist. We can assist with registration, creation of the hospital medical card and an in-person proxy visit using your materials. Any later admission remains subject to hospital rules.
Step 5 — Travel and treatment, only if a plan is agreed. After remote evaluation clarifies a feasible plan and you agree, we can coordinate arrival support, hospital communication and available green-channel logistics. Admission, scheduling and outcome are always the hospital’s decision.
Common Mistakes Families Make With a Glioma File
The same problems recur, and each one costs time.
- Sending only the most recent scan. Glioma assessment depends on comparison over time. Send the full imaging history.
- Omitting molecular results. A report that says “glioblastoma” without IDH and MGMT status is incomplete for modern planning.
- Assuming a public hospital slot can be pre-booked from abroad. Standard outpatient registration at Chinese public hospitals is generally same-day, in person, and surgery is arranged only after an in-person consultation. International departments and VIP channels are the usual route for advance scheduling, at roughly 1.5 to 2 times the standard channel price.
- Waiting for a crisis. Records take days to weeks to assemble. Starting before a neurological decline gives everyone more options.
- Expecting a guarantee. No ethical provider can promise that a specific surgeon will accept the case or that surgery will proceed.
Practical Considerations: Language, Visas, Payment and Follow-Up
Language. Top Chinese hospitals are large — some see more than 10,000 outpatients a day — and English signage is limited outside international departments. Plan for interpretation, whether through the hospital’s international office or a bilingual companion.
Visa. For medical travel, the applicable short-stay category is the S2 visa, used for medical treatment and private affairs, subject to the latest embassy or consulate requirements and supporting hospital documents. Family members accompanying a patient apply under the same category. Stays beyond 180 days fall under S1. Note that the M visa is for commercial and trade activities and is not a medical visa. Approval is never guaranteed.
Payment. Chinese public hospitals generally require prepayment, with insurance reimbursement handled afterward in your home country. Private international hospitals more often bill insurers directly. Confirm in writing which model applies to your case before traveling.
Follow-up. Glioma surveillance means regular MRI. Ask before treatment how imaging and pathology will be shared with your home team, and request copies of everything before you leave China.
Our directory of Fudan-ranked hospitals by city and the private international hospital listings can help you see what exists before you decide. For a broader view of how the system fits together, the China Medical Services homepage is a reasonable starting point.
Frequently Asked Questions
Yes. A written second opinion or video consultation allows a Chinese specialty team to review your reports remotely and give direction. It does not replace an in-person examination, and any treatment plan still requires evaluation in China.
Our service fees are separate from hospital medical charges. A written second opinion from a top hospital specialist is from $300 to $500, a top-specialist video consultation from $500 to $800, and a multidisciplinary team consultation from $1,500 to $2,000. Final pricing depends on the hospital and case complexity, and no fee is credited toward later treatment costs.
That is a legitimate and useful answer. A clear “no” from an experienced neuro-oncology team, with reasoning, can redirect you toward chemotherapy, radiotherapy or a clinical trial more quickly than months of uncertainty. We will help you understand the reasoning and pass it to your local physicians.
Your Next Step
The most useful thing you can do today is request the full DICOM files and the complete pathology report, including molecular markers. Everything else follows from that file. Our team is a medical concierge service — we are not a hospital and we do not diagnose or treat patients; we help you organize records, connect with appropriate Chinese specialists and coordinate logistics if you decide to travel. When you are ready, you can request a free consultation and we will review what you have.
This article is for general information only and does not constitute medical advice. Glioma diagnosis and treatment decisions should be made with qualified physicians who have examined you.
For more medical information and treatment options in China, visit chinamedservices.com (China Medical Services).